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Abstract
Recent theoretical calculations predicted that Gly33 of one molecule of amyloid L-peptide (1^42) (AL(1^42)) is attacked by a
putative sulfur-based free radical of methionine residue 35 of an adjacent peptide. This would lead to a carbon-centered free
radical on Gly33 that would immediately bind oxygen to form a peroxyl free radical. Such peroxyl free radicals could
contribute to the reported AL(1^42)-induced lipid peroxidation, protein oxidation, and neurotoxicity, all of which are
prevented by the chain-breaking antioxidant vitamin E. In the theoretical calculations, it was shown that no other amino acid,
only Gly, could undergo such a reaction. To test this prediction we studied the effects of substitution of Gly33 of AL(1^42) on
protein oxidation and neurotoxicity of hippocampal neurons and free radical formation in synaptosomes and in solution.
Gly33 of AL(1^42) was substituted by Val (AL(1^42G33V)). The substituted peptide showed almost no neuronal toxicity
compared to the native AL(1^42) as well as significantly lowered levels of oxidized proteins. In addition, synaptosomes
subjected to AL(1^42G33V) showed considerably lower dichlorofluorescein-dependent fluorescence ^ a measure of reactive
oxygen species (ROS) ^ in comparison to native AL(1^42) treatment. The ability of the peptides to generate ROS was also
evaluated by electron paramagnetic resonance (EPR) spin trapping methods using the ultrapure spin trap N-tert-butyl-K-
phenylnitrone (PBN). While AL(1^42) gave a strong mixture of four- and six-line PBN-derived spectra, the intensity of the
EPR signal generated by AL(1^42G33V) was far less. Finally, the ability of the peptides to form fibrils was evaluated by
electron microscopy. AL(1^42G33V) does not form fibrils nearly as well as AL(1^42) after 48 h of incubation. The results
suggest that Gly33 may be a possible site of free radical propagation processes that are initiated on Met35 of AL(1^42) and
that contribute to the peptide’s toxicity in Alzheimer’s disease brain. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Amyloid L-peptide (AL(1^42)), the chief constitu-
ent of senile plaques in Alzheimer’s disease (AD)
brain, is thought to be central to the pathogenesis
of this dementing neurodegenerative disorder [1].
The AD brain is under extensive oxidative stress,
manifested by, among other biomarkers, increased
protein oxidation [2], lipid peroxidation [3], and
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DNA and RNA oxidation [4^7] as well as elevated
levels of redox metals [8]. There is increased interest
in the role of AL(1^42) in free radical-associated neu-
rotoxicity in AD brain [9]. Although the mechanism
of AL-associated free radical oxidative stress is still
unclear, methionine residue 35 of the peptide (M35)
plays a critical role in this process [10^12]. This view
is supported by the results of a simple substitution in
the approx. 4000 Da peptide, in which the sulfur
atom of M35 is replaced by a methylene functional-
ity (^CH2^) (AL(1^42NLE)). This substitution com-
pletely abolished oxidative stress and neurotoxic
properties caused by the native peptide (i.e. oxidation
of neuronal proteins and neuronal death) [12]. Trans-
genic Caenorhabditis elegans worms, in which human
AL(1^42) is expressed, have oxidized proteins, but
substitution of M35 by a di¡erent amino acid led
to no protein oxidation [12]. Likewise, AL(25^35),
an oxidative and neurotoxic fragment of AL(1^42),
loses these properties in AL(25^34), i.e. lacking me-
thionine [10,11].
Recently, theoretical calculations based on bond
dissociation energies suggested the possibility of for-
mation of an KC-centered free radical at glycine in
antiparallel L-sheets [13]. Additionally, the glycine at
residue 33 (G33) of one AL(1^42) peptide molecule
was predicted to be susceptible to oxidation by a
methionine-based sulfuranyl free radical of a di¡er-
ent AL(1^42) molecule in a L-sheet aggregate, thus
propagating a free radical oxidative process [14].
Only the Gly at position 33 of AL(1^42) was shown
in these theoretical calculations to have potential for
H-atom abstraction by a putative sulfuranyl free rad-
ical located at M35. Since the AL(1^42) sequence
contains a glycine residue in close proximity to me-
thionine (G33 and M35), and the peptide attains a L-
sheet secondary structure upon prolonged incuba-
tion, i.e. at least two AL(1^42) chains interact, we
tested the hypothesis that the oxidative stress and
neurotoxic properties of AL(1^42) involve interaction
of M35 and G33.
Using well-established methods published in pre-
vious papers from our laboratory, we compared the
toxic behavior of native AL(1^42) and a mutant pep-
tide in which G33 was substituted with a valine
(AL(1^42G33V)), thereby precluding H-atom trans-
fer from residue 33. We report for the ¢rst time that
AL(1^42), compared to AL(1^42 G33V), displays far
greater oxidative stress and toxicity in neuronal cells
and synaptosomes and higher levels of free radicals
in solution.
2. Materials and methods
2.1. General
All chemicals used were of the highest purity and
were purchased from Sigma (St. Louis, MO, USA)
unless stated otherwise. N-tert-Butyl-K-phenylnitrone
(PBN) was synthesized according to well-established
methods [15] and subjected to rigorous puri¢cation
methods (recrystallization in hexane, and triple sub-
limation). Its purity was veri¢ed by EPR, mass spec-
trometry, and HPLC. Peptides were purchased from
US Peptide (Rancho Cucamonga, CA, USA) and
AnaSpec (San Jose, CA, USA) and both suppliers
provided evidence of purity. The peptides were
stored at 320‡C in the dry state until use.
2.2. Cell culture experiments
All experiments were conducted in accordance with
the University of Kentucky Animal Care and Use
Committee. Neuronal cultures were prepared from
18-day-old Sprague^Dawley rat fetuses as described
elsewhere [12]. AL peptides were dissolved in sterile
water that has been stirred over Chelex-100 resin. The
peptides were preincubated for 24 h before addition
to cultures. The ¢nal concentration of the peptides in
the cell was 10 WM, and the e¡ects of AL on the
neurons were measured after 24 h of exposure.
Neuronal survival was evaluated by the Trypan
blue exclusion assay. Cells were rinsed three times
with 1 ml PBS (pH 7.4) after exposure to the pep-
tides. Trypan blue was added to cells along with 300
Wl PBS and incubated for 10 min. Sixteen di¡erent
microscopic areas were counted for uptake of Try-
pan blue. Data are given as percentages of corre-
sponding vehicle-treated values [16].
To determine the level of protein oxidation an
Oxidized Protein Detection Kit (Intergen, Purchase,
NY, USA) was used. This kit is based on immuno-
chemical detection of protein carbonyl groups deriv-
atized with 2,4-dinitrophenylhydrazine (DNPH). The
experimental procedure used is described in detail
BBADIS 62080 10-4-02
J. Kanski et al. / Biochimica et Biophysica Acta 1586 (2001) 190^198 191
elsewhere [11,17]. Data are given as percentages of
corresponding controls.
2.3. Preparation of synaptosomal membrane systems
The synapse is thought to be the ¢rst target of
attack in neurons in AD [18], and soluble AL(1^42)
is reportedly a good predictor of synapse loss in this
disorder [19]. Accordingly, we employed synapto-
somes as well as neuronal cultures in this study.
Three-month-old male Mongolian gerbils were used
to obtain synaptosomes. The procedure for isolation
of synaptosomes using discontinuous sucrose gra-
dients has been described elsewhere [20]. Brie£y, the
animals were sacri¢ced by decapitation, and the
brain was isolated immediately. The cortex was
placed in 0.32 M sucrose isolation bu¡er containing
4 Wg/ml leupeptin, 4 Wg/ml pepstatin, 5 Wg/ml apro-
tinin, 20 Wg/ml trypsin inhibitor, 2 mM ethylene gly-
col-bistetraacetic acid (EGTA), 2 mM ethylenediami-
netetraacetic acid (EDTA), and 20 mM 4-(2-
hydroxyethyl)-1-piperazine-ethanesulfonic acid
(HEPES), pH 7.4). Samples were then homogenized
by passing in the tube a motor driven pestle 10 times.
The homogenate tissue was then centrifuged at
1500Ug for 10 min. The supernatant was collected
and spun at 20 000Ug for 10 min. The pellet was
removed and placed on the top of a discontinuous
sucrose gradient (0.85 M, pH 8.0; 1 M, pH 8.0; and
1.18 M, pH 8.5 sucrose solutions each containing 10
mM HEPES, 2 mM EDTA, and 2 mM EGTA) and
spun in a Beckman L7-55 ultracentrifuge at
82 500Ug for 2 h at 4‡C. The synaptosomal layer
was collected at the 1/1.18 molar sucrose interface,
and subsequently washed twice with PBS for 10 min
at 32 000Ug yielding synaptosomal membranes. Pro-
tein concentration was determined by the BCA meth-
od on a Bio-tek Instruments PowerWaveX UV-Vis
microtiter plate reader.
2.4. Reactive oxygen species (ROS) measurements
For the dichloro£uorescein (DCF) assay for ROS,
synaptosomes (1 mg/ml) were dissolved in PBS and
incubated with 10 WM of non-£uorescent dichloro-
£uorescin diacetate (DCFH-DA) for 30 min followed
by a cell wash in an Eppendorf centrifuge (3000Ug
for 5 min). Dichloro£uorescin (DCFH), formed by
esterase cleavage of the diester, is a dianion and can-
not exit the synaptosomes. Reaction of this dianion
with ROS leads to £uorescent DCF. Synaptosomes
were resuspended in 0.5 ml of PBS, and 100 Wl ali-
quots were redistributed to a black, 96-well, micro-
titer plate (Corning, Acton, MA, USA). Fluores-
cence was triggered by oxidation of DCFH to DCF
following addition of 10 WM of AL peptides that
were previously preincubated for 8 h at 37‡C. The
measurements were performed on a Molecular Devi-
ces SpectraMax GeminiXS microtiter plate reader
with Vex = 485 nm and Vem = 530 nm. Data are given
as percentage of corresponding controls.
2.5. EPR spin trapping
The fresh peptides (165 WM) were solubilized in
PBS bu¡er containing PBN (50 mM). The bu¡er
was stirred overnight in the presence of Chelex-100
resin, and the chelator deferoxamine mesylate (2
mM) was dissolved in the bu¡er prior to peptide
addition. The peptides, along with a control solution
that lacked the peptides, were incubated at 37‡C for
up to 72 h. The EPR spectra were acquired on a
Bruker EMX EPR spectrometer. Instrumental pa-
rameters were as follows: microwave power 20
mW, modulation amplitude 1 G, gain 1U105, and
conversion time 10.28 ms.
2.6. Electron microscopy
The ability of the full-length AL peptides to form
¢brils upon incubation in solution for 48 h was as-
sessed by electron microscopy. Aliquots of 5 Wl of the
peptide solutions that were used for the cell culture
experiments were placed on a copper formvar car-
bon-coated grid. After 1^1.5 min of incubation at
room temperature, excess liquid was drawn o¡, and
samples were counterstained with 2% uranyl acetate.
Air-dried samples were examined in a Hitachi 7000
transmission electron microscope at 75 kV.
2.7. Thio£avin T binding assay
Thio£avin T (ThT) binding assay was performed
according to well-established protocols [21]. Brie£y,
to a fresh 4.54 WM solution of ThT (dissolved in 50
mM glycine solution, pH 8.5) incubated AL peptides
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(24 and 48 h incubation) solutions were added to
make 10 WM mixture. The resulting £uorescence
was measured on a Molecular Devices SpectraMax
GeminiXS microtiter plate reader with Vex = 440 nm
and Vem = 485 nm. The results are presented as mean
and S.D. of three separate measurements.
2.8. Statistics
ANOVA was used to assess the signi¢cance; P
values less than 0.05 were considered signi¢cant.
3. Results and discussion
To investigate the e¡ect of G33 on AL(1^42)-in-
duced oxidative stress and neurotoxicity, cultured
hippocampal neuronal cells prepared from 18-day-
old Sprague^Dawley rat fetuses were treated with
10 WM of AL(1^42) or AL(1^42G33V). After 24 h
of exposure of the respective peptides, oxidative
stress and neurotoxicity were assessed by measure-
ment of protein carbonyl levels and the Trypan
blue exclusion assay, respectively, using well-estab-
lished methods [9,12]. Fig. 1A summarizes the re-
sults; the values were normalized to the respective
controls. While the native peptide displays signi¢-
cantly elevated levels of protein carbonyls ^ a hall-
mark of protein oxidation [22] ^ and considerable
cell death (P6 0.00002 and P6 0.00001 in both cases
for AL(1^42)), the G33V-substituted peptide only
oxidized neuronal proteins to a small extent, and
there was no signi¢cant cell death caused by the mu-
tant peptide (Fig. 1A). Relative to each other, native
AL(1^42) causes far more neuronal protein oxidation
and neurotoxicity than does AL(1^42G33V)
(P6 0.008 (*) and P6 0.00027 (**), respectively).
Often DCFH-DA, a cell permeable dye, is used to
assess the levels of ROS in vitro [23]. Synaptosomal
membrane systems from Mongolian gerbil cortexes
were prepared and preincubated with 10 WM of neu-
tral DCFH-DA for 30 min. As described in Section
2, oxidation of DCFH to DCF leads to £uorescence.
Fig. 1B shows the time course of peptide-induced
DCF £uorescence in synaptosomes; the results are
normalized to the values obtained for the control
samples. The levels of ROS generated by the peptides
are considerably greater for the native AL(1^42) than
Fig. 1. (A) Levels of oxidation and neurotoxicity in cultured
neurons treated with 10 WM of the peptides for 24 h. Protein
oxidation (black bars) was indexed by protein carbonyl levels
determined immunochemically and whose images were digitized
and quanti¢ed using Scion Image software (Frederick, MD,
USA). Cell death was determined by Trypan blue exclusion
(dark gray bars). Dead cells take up the dye, while live cells do
not. The numbers for each measure are normalized to respec-
tive controls and displayed in groups for AL(1^42) and AL(1^
42G33V), respectively. The results are given as the mean þ S.D.
of three di¡erent experiments (*P6 0.008 and **P6 0.00027
for a measure between the two peptides for carbonyls and Try-
pan blue assay, respectively). (B) ROS induces DCF £uores-
cence in synaptosomes upon treatment with the peptides. Syn-
aptosomes (1 mg protein/ml in PBS, pH 7.4) were loaded with
10 WM of DCFH-DA and incubated for 30 min at room tem-
perature. After the incubations, the cells were washed and re-
suspended in PBS. The £uorescence was triggered by addition
of 10 WM of the peptide. The results are normalized to the con-
trol samples and are shown as mean þ S.D. of three di¡erent
experiments (*P6 0.03 for comparison between two peptide
samples). b, AL(1^42); a, AL(1^42G33V).
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that of AL(1^42G33V). We previously showed that
M35 was critical to the oxidative and neurotoxic
properties of AL(1^42) [12,24]. The results in Fig.
1A,B are consistent with the notion that the presence
of G33 also may be an important factor in these
properties of AL(1^42), possibly involving propaga-
tion events between the peptide chains.
Fig. 2 displays the EPR spectra of the peptides
(165 WM) incubated with 50 mM of the ultrapure
spin trap PBN for 72 h at 37‡C in cell-free solution.
The native AL(1^42) peptide is responsible for for-
mation of a strong four-line and weaker six-line EPR
spectrum as reported previously and con¢rmed by
others [9,25]. In contrast, the EPR intensity of
AL(1^42G33V) is far less than that of native AL(1^
42), consistent with the decreased protein oxidation
and neurotoxicity of the glycine-substituted peptide.
Control experiments with PBN alone show no EPR
signal.
We addressed the issue of ¢brilogenesis of the sub-
stituted peptide. The role of AL aggregation and its
consequence for pathogenesis of AD is an important
issue in AD research. Formation of ¢brils was shown
to be important in toxicity mechanisms of AL [26^
28]. However, in the presence of speci¢c proteins,
small, soluble aggregated AL peptides are formed
that are highly toxic species, yet no ¢brils appeared
[29^32]. In this study, the ability of AL(1^42G33V)
to form ¢brils upon incubation in solution for 24^48
h was investigated by electron microscopy. Fig. 3
shows EM images of AL(1^42) and AL(1^42G33V)
taken at 75 kV at 30 000U magni¢cation. As re-
ported previously [9,33], AL(1^42) clearly formed
an extensive network of ¢brils (Fig. 3A). The G33V
substituted peptide formed only scarce aggregates
(Fig. 3B) even viewed at higher magni¢cation
(70 000U). We have veri¢ed this ¢nding by the
ThT binding assay, which indexes the presence of
L-sheets. As presented in Table 1, aggregated native
AL(1^42) binds ThT to a far greater extent than does
the G33V mutant, suggesting that upon incubation
the AL(1^42) secondary structure has the L-sheet
conformation necessary for aggregation. In the light
of this work and previous reports, the role of ¢brilo-
genesis of AL is still unclear. Our previous ¢ndings
revealed that non-oxidative and non-neurotoxic
AL(1^42NLE) still generated ¢brils [9,33]. In addi-
tion, aggregation of AL(1^42) cannot be prevented
by the antioxidant vitamin E [34], an antioxidant
that e¡ectively prevents neuronal death and neuronal
protein oxidation caused by AL(1^42) [34].
Aggregation of AL(1^42) conceivably could be a
consequence of the oxidation of M35. Methionine
can be easily oxidized under relatively mild condi-
tions leading to formation of methionine sulfoxide
Fig. 3. Electron microscopy of (A) AL(1^42) and (B) AL(1^
42G33V) incubated for 48 h. AL(1^42G33V) solutions show
lack of extensive ¢brils compared to AL(1^42) solutions in
which ¢brils are present. Magni¢cation is 30 000U in A and
70 000U in B.
Table 1
Thio£avin T binding assay for the peptides
Peptide AL(1^42) AL(1^42G33V)
Fluorescence intensity 702 þ 42 178 þ 5
The results are mean þ S.D. of three di¡erent measurements.
Fig. 2. EPR spectra of peptides (165 WM) individually incu-
bated with 50 mM of ultrapure PBN in the presence of 2 mM
deferoxamine mesylate in water stored over Chelex-100. The
PBN spin trap used was of the highest purity ensured by re-
peated recrystallizations and sublimations and veri¢ed by
HPLC and MS analyses. (A) Control solution, (B) AL(1^42),
and (C) AL(1^42G33V) after 72 h of incubation at 37‡C.
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via several possible pathways [35,36]. As predicted
from theoretical calculations [14], a radical formed
on methionine can possibly abstract a H-atom from
the neighboring G33 amino acid of an adjacent pep-
tide, leading to formation of an KC-centered radical
on the peptide backbone (structure 1 in Fig. 4). Sev-
eral possible pathways are possible at this stage of
reaction. Two G33 radicals could combine to form a
covalent dimer of AL(1^42). This is highly unlikely,
because of steric issues, plus oxygen likely will get to
the radical site quicker, resulting in the di¡usion-con-
trolled reaction of a Cc radical with molecular oxy-
gen to form a peroxyl radical on the peptide. This
latter possibility is consistent with the experimental
observation that the toxicity of AL(25^35) was abol-
ished in the presence of catalase [37]. Moreover, a
radical propagation step is possible, in which there
is radical transfer between the G33 residues of two
antiparallel L-strands of AL(1^42) [13] or between
AL(1^42) and a lipid chain or another peptide or
protein [9,10,38]. The latter would form a lipid rad-
ical or protein radical that would immediately bind
paramagnetic oxygen, forming a peroxyl lipid or pro-
tein radical. Additionally, such peroxyl radicals can,
in certain cases, form protein carbonyls or the reac-
tive lipid reaction products, hydroxynonenal or acro-
lein, each of which are elevated in AD brain
[2,3,39,40].
The possibility of an alternate peroxyl free radical
pathway exists, one that does not involve Gly33, but
rather involves H-atom abstraction from the methyl
group bonded to the sulfuramyl radical forming an
K-(alkylthio)alkyl radical (structure 2 in Fig. 4) [41].
The latter, C-center radical would undergo a di¡u-
Fig. 4. Possible pathways for methionine-initiated free radical pathways that involve G33 (1) or the terminal methyl group of the K-
(alkylthio)alkyl radical (2), both leading to peroxyl free radical formation. Subsequent free radical reactions with proteins or lipids
could lead to the reported vitamin E-inhibited protein or lipid oxidation and neurotoxicity induced by AL(1^42).
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sion-controlled reaction with molecular oxygen lead-
ing to the formation of peroxyl radicals that can
undergo similar reactions as in the case of the gly-
cine-derived KC-centered radical on the peptide back-
bone discussed above. In either case, AL(1^42)-asso-
ciated free radical-induced oxidative stress and
neurotoxicity, in processes that critically depend on
the methionine residue and that are inhibited by vi-
tamin E [9,11,12,34,42], lead to lipid peroxidation,
protein oxidation, ROS formation, and neuronal
death.
Others have suggested that AL(1^42) is a redox
metal ion carrier that facilitates transfer of the redox
metal ion to the membrane where the oxidative pro-
cesses associated with Fenton-type chemistry can oc-
cur [43]. This was supported by the cell survival stud-
ies in which cell cultures treated with AL and Fe(III/
II) showed greatly decreased survival, an e¡ect that
was inhibited by the chelator deferoxamine. Our re-
sults are not inconsistent with this ¢nding, only we
believe it is the methionine residue 35 that facilitates
the oxidative process. This hypothesis is strengthened
by the recent results of Curtain et al. [44], who
showed that AL(1^28) could not reduce Cu(II) nor
was it toxic. Yet, all the principal metal binding sites
are present, e.g. His6, 13, 14 as well as Glu22. As
noted above, we showed earlier that if Met were
replaced by norleucine (a simple substitution of a
CH2 for the S-atom in Met, the only change in the
entire 4000 Da peptide), and additional Cu(II) were
added, there was still not toxicity nor oxidative stress
to neurons, in marked contrast to native AL(1^42)
[9]. Curtain et al. [44] showed that if exogenous Met
were added to the non-active AL(1^28), then Cu(II)
reduction took place.
Given the suggested centrality of AL(1^42) to the
pathogenesis of AD, such processes may be impor-
tant for neurodegeneration in AD brain. Additional
experiments are underway to elucidate the chemical
mechanisms underlying the role of G33 in AL(1^42)
free radical oxidative stress processes.
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